SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
83 hedge funds and large institutions have $75.2M invested in Sorrento Therapeutics, Inc. in 2019 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
-1
Holders Change %
-1.19%
% of All Funds
1.81%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
10
Increased
34
Reduced
17
Closed
9
Calls
$1.57M
Puts
$1.15M
Net Calls
+$422K
Net Calls Change
-$44K
Top Buyers
| 1 |
DM
Deerfield Management
New York
|
+$5.58M |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$3.74M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$1.77M |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$1.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.06M |
Top Sellers
| 1 |
D.E. Shaw & Co
New York
|
-$324K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$260K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$247K |
| 4 |
Morgan Stanley
New York
|
-$246K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$182K |
